Abstract:Graphical and Lay Summary The application of the Design‐Build‐Test‐Learn (DBTL) framework in enhancing erythromycin production from Saccharopolyspora erythraea. Through systematic metabolic engineering, a genetically modified strain was developed, showing improved erythromycin synthesis by suppressing the sucC gene and enhancing NADPH availability. Transcriptomic and metabolomic analyses revealed significant metabolic alterations, particularly in central carbon, amino acid, energy, and co‐factor/vitamin metabolism pathways. Despite increased amino acid metabolism leading to nitrogen depletion and potential cellular autolysis during fermentation, refining the process through ammonium sulfate supplementation resulted in a remarkable 43.5% increase in erythromycin yield (1125.66 mg/L). This work highlights the efficacy of the DBTL methodology in optimizing antibiotic production and offers insights into addressing the global challenge of antibiotic resistance. Industrial production of bioactive compounds from actinobacteria, such as erythromycin and its derivatives, faces challenges in achieving optimal yields. To this end, the Design‐Build‐Test‐Learn (DBTL) framework, a systematic metabolic engineering approach, was employed to enhance erythromycin production in Saccharopolyspora erythraea (S. erythraea) E3 strain. A genetically modified strain, S. erythraea E3‐CymRP21‐dcas9‐sucC (S. erythraea CS), was developed by suppressing the sucC gene using an inducible promoter and dcas9 protein. The strain exhibited improved erythromycin synthesis, attributed to enhanced precursor synthesis and increased NADPH availability. Transcriptomic and metabolomic analyses revealed altered central carbon metabolism, amino acid metabolism, energy metabolism, and co‐factor/vitamin metabolism in CS. Augmented amino acid metabolism led to nitrogen depletion, potentially causing cellular autolysis during later fermentation stages. By refining the fermentation process through ammonium sulfate supplementation, erythromycin yield reached 1125.66 mg L−1, a 43.5% increase. The results demonstrate the power of the DBTL methodology in optimizing erythromycin production, shedding light on its potential for revolutionizing antibiotic manufacturing in response to the global challenge of antibiotic resistance.

Molecular variation of the nonribosomal peptide-polyketide siderophore yersiniabactin through biosynthetic and metabolic engineering.

Total Biosynthesis and Diverse Applications for the Nonribosomal Peptide-Polyketide Siderophore Yersiniabactin

Consolidated Plasmid Design for Stabilized Heterologous Production of the Complex Natural Product Siderophore Yersiniabactin.

Heterologous erythromycin production across strain and plasmid construction

Tailoring Pathway Modularity in the Biosynthesis of Erythromycin Analogs Heterologously Engineered in E. Coli

Expanding the substrate selectivity of the fimsbactin biosynthetic adenylation domain, FbsH

Broadened Glycosylation Patterning of Heterologously Produced Erythromycin

Effects of exogenous nutrients on polyketide biosynthesis in Escherichia coli

Generation of tetramycin B derivative with improved pharmacological property based on pathway engineering

Enhancing erythromycin production in Saccharopolyspora erythraea through rational engineering and fermentation refinement: A Design‐Build‐Test‐Learn approach

Redirection of acyl donor metabolic flux for lipopeptide A40926B0 biosynthesis

First-class - biosynthesis of 6-MSA and bostrycoidin type I polyketides in Yarrowia lipolytica

Precursor supply for erythromycin biosynthesis: engineering of propionate assimilation pathway based on propionylation modification.

Modular co-culture engineering of Yarrowia lipolytica for amorphadiene biosynthesis

Exploiting synthetic biology platforms for enhanced biosynthesis of natural products in Yarrowia lipolytica

Rational construction of a high-quality and high-efficiency biosynthetic system and fermentation optimization for A82846B based on combinatorial strategies in Amycolatopsis orientalis

Biosynthesis of novel non-proteinogenic amino acids β-hydroxyenduracididine and β-methylphenylalanine in Escherichia coli

Biosynthesis of β-lactam nuclei in yeast

Biosynthesis of -lactam nuclei in yeast

Engineered EryF Hydroxylase Improving Heterologous Polyketide Erythronolide B Production in Escherichia Coli

Biosynthetic pathway for high structural diversity of a common dilactone core in antimycin production.